Es wurden 17 Aussendungen gefunden
  • Valneva SE
EANS-Adhoc: Valneva SE / ACIP Unanimously Votes to Extend the Recommendations for Use of IXIARO® Vaccine

-------------------------------------------------------------------------------- ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the...

  • 21.06.2013, 08:48:14
  • /
  • OTE0002
  • Intercell AG
EANS-Adhoc: Intercell announces Q2 and H1 2011 financial results and provides an update on execution of strategic plan

-------------------------------------------------------------------------------- ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the...

  • 16.08.2011, 07:21:22
  • /
  • OTE0002
  • Intercell AG
EANS-Adhoc: Intercell AG / Intercell announces new management structure: Thomas Lingelbach appointed new CEO; new Supervisory Board members proposed

-------------------------------------------------------------------------------- ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the...

  • 05.05.2011, 07:32:35
  • /
  • OTS0004 OTW0004
  • Intercell AG
EANS-News: Intercell announces initial results of Phase II clinical trial evaluating V710, an investigational Staphylococcus aureus vaccine, in patients with end-stage renal disease

-------------------------------------------------------------------------------- Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. --------------------------------------------------------------------------------...

  • 18.11.2010, 07:53:44
  • /
  • OTE0002
  • Intercell AG
EANS-Adhoc: Intercell: Primäre Ergebnisse der ersten Phase I-Studie mit dem Impfstoffkandidaten gegen Streptokokkus pneumoniae

-------------------------------------------------------------------------------- Ad-hoc-Mitteilung übermittelt durch euro adhoc mit dem Ziel einer europaweiten Verbreitung. Für den Inhalt ist der Emittent...

  • 11.02.2010, 08:00:01
  • /
  • OTS0007 OTW0007
  • Intercell AG
EANS-Adhoc: Intercell obtains results from its first Phase I investigational vaccine study for Streptococcus pneumoniae

-------------------------------------------------------------------------------- ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the...

  • 11.02.2010, 08:00:01
  • /
  • OTS0006 OTW0006
  • Intercell AG
EANS-News: Intercell announces initiation in the U.S. of a Phase III study for vaccine to protect children against Japanese Encephalitis

-------------------------------------------------------------------------------- Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. --------------------------------------------------------------------------------...

  • 28.12.2009, 08:26:26
  • /
  • OTE0001
  • Intercell AG
EANS-Adhoc: Intercell AG Announces Q3 2009 Results and Updates on R&D Progress and Management:

-------------------------------------------------------------------------------- ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the...

  • 09.11.2009, 07:28:07
  • /
  • OTS0003 OTW0003
EANS-Adhoc: Intercell AG announces Q2 and H1 2009 results and business update:

» Realizing IXIARO®'s commercial potential through global launch activities and market expansion

  • 17.08.2009, 07:17:40
  • /
  • OTE0001
EANS-Adhoc: Intercell AG announces Q2 and H1 2009 results and business update:

» Realizing IXIARO®'s commercial potential through global launch activities and market expansion

  • 17.08.2009, 07:17:40
  • /
  • OTS0003 OTW0003

Aussendersuche